Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $5.84 $8.40 Friday, 10th May 2024 VERV stock ended at $6.01. This is 5.50% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 9.35% from a day low at $5.88 to a day high of $6.43.
90 days $5.84 $19.34
52 weeks $5.84 $21.42

Historical Verve Therapeutics, Inc. prices

Date Open High Low Close Volume
Dec 20, 2021 $38.09 $39.92 $36.69 $39.20 615 332
Dec 17, 2021 $34.82 $40.35 $33.99 $39.27 4 759 889
Dec 16, 2021 $35.02 $36.22 $34.24 $34.88 665 800
Dec 15, 2021 $32.81 $35.39 $32.13 $34.44 761 433
Dec 14, 2021 $32.01 $34.40 $31.64 $33.11 654 045
Dec 13, 2021 $32.69 $35.49 $31.46 $33.19 420 167
Dec 10, 2021 $32.88 $34.37 $32.18 $32.66 281 006
Dec 09, 2021 $35.65 $36.91 $33.00 $33.13 410 335
Dec 08, 2021 $35.17 $36.98 $34.62 $35.99 362 601
Dec 07, 2021 $32.88 $36.29 $32.88 $35.74 530 765
Dec 06, 2021 $32.95 $33.34 $30.26 $32.16 320 260
Dec 03, 2021 $33.11 $33.34 $29.87 $31.94 514 228
Dec 02, 2021 $33.07 $34.08 $30.75 $32.94 421 062
Dec 01, 2021 $35.10 $35.32 $32.70 $33.31 500 785
Nov 30, 2021 $33.30 $35.47 $32.31 $34.08 762 778
Nov 29, 2021 $33.93 $35.03 $32.81 $33.25 352 181
Nov 26, 2021 $35.16 $37.06 $33.15 $33.15 219 937
Nov 24, 2021 $35.05 $37.12 $33.92 $35.74 340 551
Nov 23, 2021 $38.20 $38.20 $33.54 $35.06 792 329
Nov 22, 2021 $42.07 $42.07 $37.78 $38.53 553 806
Nov 19, 2021 $41.15 $43.32 $40.82 $41.30 304 653
Nov 18, 2021 $41.56 $42.44 $40.15 $41.28 338 703
Nov 17, 2021 $44.99 $46.67 $40.98 $41.39 351 584
Nov 16, 2021 $45.61 $46.05 $44.11 $44.97 192 764
Nov 15, 2021 $48.52 $48.52 $44.27 $46.00 353 763
Click to get the best stock tips daily for free!

About Verve Therapeutics, Inc.

Verve Therapeutics. Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with... VERV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT